Education
About Us
Working with TipRanks
Follow Us
West Pharmaceutical Services, Inc. (WST)
NYSE:WST
WST Analyst Ratings
Strong Buy
9 Buy
2 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
WST Stock 12 Month Forecast
Average Price Target
$310.28
▲(31.78% Upside)
| Highest Price Target$375.00 | Average Price Target$310.28 | Lowest Price Target$248.06 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Citi
$375
Buy
59.26%
Upside
Reiterated
03/09/26
William Blair
$248.06
Buy
5.35%
Upside
Assigned
03/09/26
Morgan Stanley
$285
Hold
21.04%
Upside
Reiterated
02/17/26
UBS
$355→$340
Buy
44.40%
Upside
Reiterated
02/13/26
Bank of America Securities
$370→$300
Buy
27.41%
Upside
Reiterated
02/13/26
Deutsche Bank
$310→$315
Buy
33.78%
Upside
Reiterated
02/13/26
Barclays
$325→$265
Hold
12.55%
Upside
Reiterated
02/13/26
TD Cowen
$350
Buy
48.65%
Upside
Reiterated
02/12/26
Jefferies
$365→$295
Buy
25.29%
Upside
Reiterated
02/10/26
Evercore ISI
$320
Buy
35.90%
Upside
Reiterated
02/03/26
DBS
$320
Buy
35.90%
Upside
Reiterated
01/28/26
Nephron
$367
Buy
55.87%
Upside
Upgraded
12/11/25
KeyBanc
$325→$350
Buy
48.65%
Upside
Reiterated
10/24/25
Rothschild & Co Redburn
$311
Buy
32.08%
Upside
Initiated
09/15/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Citi
$375
Buy
59.26%
Upside
Reiterated
03/09/26
William Blair
$248.06
Buy
5.35%
Upside
Assigned
03/09/26
Morgan Stanley
$285
Hold
21.04%
Upside
Reiterated
02/17/26
UBS
$355→$340
Buy
44.40%
Upside
Reiterated
02/13/26
Bank of America Securities
$370→$300
Buy
27.41%
Upside
Reiterated
02/13/26
Deutsche Bank
$310→$315
Buy
33.78%
Upside
Reiterated
02/13/26
Barclays
$325→$265
Hold
12.55%
Upside
Reiterated
02/13/26
TD Cowen
$350
Buy
48.65%
Upside
Reiterated
02/12/26
Jefferies
$365→$295
Buy
25.29%
Upside
Reiterated
02/10/26
Evercore ISI
$320
Buy
35.90%
Upside
Reiterated
02/03/26
DBS
$320
Buy
35.90%
Upside
Reiterated
01/28/26
Nephron
$367
Buy
55.87%
Upside
Upgraded
12/11/25
KeyBanc
$325→$350
Buy
48.65%
Upside
Reiterated
10/24/25
Rothschild & Co Redburn
$311
Buy
32.08%
Upside
Initiated
09/15/25
Best Analysts Covering West Pharmaceutical Services
3 Months
xxx
Success Rate
9/14 ratings generated profit
Average Return
+5.76%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 64.29% of your transactions generating a profit, with an average return of +5.76% per trade.
1 Year
Success Rate
9/14 ratings generated profit
Average Return
+9.11%
reiterated a buy rating 5 months ago
Copying Paul Knight's trades and holding each position for 1 Year would result in 64.29% of your transactions generating a profit, with an average return of +9.11% per trade.
2 Years
xxx
Success Rate
8/14 ratings generated profit
Average Return
+13.89%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 57.14% of your transactions generating a profit, with an average return of +13.89% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
WST Analyst Recommendation Trends
Rating
Nov 25
Dec 25
Jan 26
Feb 26
Mar 26
Strong Buy
0
0
1
1
2
Buy
28
31
18
29
25
Hold
9
14
16
19
14
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
37
45
35
49
41
Each month's total comprises the sum of three months' worth of ratings.
WST Financial Forecast
WST Stock Forecast FAQ
What is WST’s average 12-month price target, according to analysts?
Based on analyst ratings, West Pharmaceutical Services, Inc.’s 12-month average price target is 310.28.
What is WST’s upside potential, based on the analysts’ average price target?
West Pharmaceutical Services, Inc. has 31.78% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is WST a Buy, Sell or Hold?
West Pharmaceutical Services, Inc. has a consensus rating of Strong Buy which is based on 9 buy ratings, 2 hold ratings and 0 sell ratings.
What is West Pharmaceutical Services, Inc.’s price target?
The average price target for West Pharmaceutical Services, Inc. is 310.28. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $375.00 ,the lowest forecast is $248.06. The average price target represents 31.78% Increase from the current price of $235.46.
The highest analyst price target is $375.00 ,the lowest forecast is $248.06. The average price target represents 31.78% Increase from the current price of $235.46.
What do analysts say about West Pharmaceutical Services, Inc.?
West Pharmaceutical Services, Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 11 Wall Streets Analysts.
How can I buy shares of WST?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.